| JXSB2400012 | ACZ885 | canakinumab | Injection | Biological Products(1) | Supplementary Application | 2024-02-05 | | Novartis Pharma Stein AG;Novartis Pharma Schweiz AG | | | view |
| JXSB2300039 | ACZ885注射液 | canakinumab | Injection | Biological Products(2.2) | Supplementary Application | 2023-04-11 | | Novartis Pharma Stein AG;Novartis Pharma Schweiz AG | | | view |
| JXSB2300019 | ACZ885 | canakinumab | Injection | Biological Products(1) | Supplementary Application | 2023-02-21 | | Novartis Pharma Stein AG;Novartis Pharma Schweiz AG | | | view |
| JXSL2200063 | ACZ885 | canakinumab | Injection | Biological Products(2.2) | Import Drug Application | 2022-05-26 | | China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG | | | view |
| JXSL2200064 | ACZ885 | canakinumab | Injection | Biological Products(2.2) | Import Drug Application | 2022-05-26 | | China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG | | | view |
| JXSL2100046 | ACZ885注射液 | canakinumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-04-01 | 诺华（中国）生物医学研究有限公司 | China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG | In Review | 2021-03-31 | view |
| JXSL1800040 | ACZ885 | canakinumab | Injection | Biological Products | Import Drug Application | 2018-10-29 | Novartis Pharma AG | Novartis Pharma Schweiz AG | In Review | 2018-10-27 | view |
| JXSL1800042 | ACZ885 | canakinumab | Injection | Biological Products | Import Drug Application | 2018-10-29 | Novartis Pharma AG | Novartis Pharma Schweiz AG | In Review | 2018-10-27 | view |
| JXSL1800041 | ACZ885 | canakinumab | Injection | Biological Products | Import Drug Application | 2018-10-26 | Novartis Pharma AG | Novartis Pharma Schweiz AG | In Review | 2018-10-25 | view |
| JXSL1800043 | ACZ885 | canakinumab | Injection | Biological Products | Import Drug Application | 2018-10-26 | Novartis Pharma AG | Novartis Pharma Schweiz AG | In Review | 2018-10-25 | view |
| JXSL1800007 | ACZ885 | canakinumab | Injection | Biological Products | Import Drug Application | 2018-02-22 | Novartis Pharma AG | Novartis Pharma Schweiz AG | Certificate Issued | 2018-08-27 | view |
| JXSL1800006 | ACZ885 | canakinumab | Injection | Biological Products | Import Drug Application | 2018-02-22 | Novartis Pharma AG | Novartis Pharma Schweiz AG | Certificate Issued | 2018-08-27 | view |
| JXSL1600020 | ACZ885 | canakinumab | Injection | Biological Products | Import Drug Application | 2016-04-13 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG | Certificate Issued | 2017-10-16 | view |
| JXSL1600018 | ACZ885 | canakinumab | Injection | Biological Products | Import Drug Application | 2016-04-13 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG | Certificate Issued | 2017-10-16 | view |
| JXSL1100049 | ACZ885 | canakinumab | Injection | Biological Products | Import Drug Application | 2011-09-30 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG | Certificate Issued | 2012-06-08 | view |
| JXSL1100010 | ACZ885 | canakinumab | Injection | Biological Products | Import Drug Application | 2011-03-03 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG | Certificate Issued | 2012-05-28 | view |
| JXSL0900072 | ACZ885 | canakinumab | Injection | Biological Products | Import Drug Application | 2009-10-16 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG | Certificate Issued | 2010-11-23 | view |
